Abstract Details

Title Post-Marketing Safety Profile of Interferon Beta-1a Subcutaneously in Patients with Multiple Sclerosis Treated in the US: A Retrospective Cohort Study

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 268

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Florent Richy, PhD	No disclosure on file
Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel)	Dr. Kappos has nothing to disclose.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��